Background Cannabis is increasingly available worldwide but its impact on cognition in
Parkinson's disease (PD) is unknown. Objective Present cognitive safety data from study of …

Background Individuals with an Opioid Use Disorder (OUD) have increased rates of
cannabis use in comparison to the general population. Research on the short-and long-term …

Gut bacteria plays a leading role in the pharmacological actions of both synthetic and
natural product derived drugs. Their interactions are complex and bidirectional. This …

Cannabis products are widely used for medical and non-medical reasons worldwide and
vary in content of cannabinoids such as delta-9-tetrahydrocannabinol (THC) and …

Polysubstance use (ie, simultaneous or sequential use of different psychoactive substances)
is associated with increases in the risk of severe health problems and social impairments …

The potential use of cannabidiol (CBD) as a nutraceutical to support improved health and
welfare has been of increasing interest. In particular, CBD has been shown to decrease …

BackgroundAcute cannabis administration can produce transient psychotic-like effects in
healthy individuals. However, the mechanisms through which this occurs and which factors …

Background Although δ-9-tetrahydrocannabinol (THC), the main cannabinoid from the
cannabis plant, is responsible for the psychotomimetic effects of cannabis, cannabidiol …

Background Although cannabis use is common in France, it is still criminalized. Cannabidiol
(CBD) products, including CBD-rich cannabis, are legally available. Although previous …

Cannabidiol (CBD) is a non-psychotomimetic compound present in cannabis sativa. Many
recent studies have indicated that CBD has a promising therapeutic profile for stress-related …